Risk minimization measures
| Scientific Name | Brand name | Approval Date | Last Update | Details |
|---|---|---|---|---|
| Apixaban | Plasiv | Details | ||
| Isotretinoin | Roaccutane | Details | ||
| Dabigatran | Pradaxa | Details | ||
| Natalizumab | Tysabri | Details | ||
| Paracetamol, Caffeine, Codeine Phosphate | Solpadeine | Details | ||
| Cyproterone acetate/Ethinylestradiol | Diane- 35 | Details | ||
| Dasatinib | Sprycel | Details | ||
| Bevacizumab | Avastin | Details | ||
| Leflunomide | Arava | Details | ||
| Drospirenone, Ethinylestradiol | Yasmin | Details |
